Total planned funding: $638,981,778
Clear active filters
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Tanzania | $70,136,996 |
| Ethiopia | $69,222,650 |
| Nigeria | $68,991,632 |
| Zambia | $66,509,650 |
| South Africa | $58,168,976 |
| Côte d'Ivoire | $45,332,283 |
| Kenya | $44,651,782 |
| Uganda | $41,226,490 |
| Namibia | $33,187,088 |
| Mozambique | $31,072,415 |
| Vietnam | $24,832,144 |
| Rwanda | $21,762,256 |
| Zimbabwe | $14,010,000 |
| Haiti | $9,681,170 |
| Botswana | $9,220,785 |
| Caribbean Region | $8,118,000 |
| Malawi | $5,121,100 |
| Guyana | $5,104,712 |
| Eswatini | $3,294,249 |
| Lesotho | $2,311,000 |
| China | $1,954,500 |
| Angola | $1,619,000 |
| Russia | $1,510,000 |
| Ghana | $1,100,000 |
| Thailand | $842,900 |
| South Sudan | $0 |
| Ukraine | $0 |
Organizational Types
| Private Contractor | $638,981,778 |
Program Areas
| Treatment | $266,110,848 |
| Governance and Systems | $118,260,056 |
| Prevention | $112,052,467 |
| Care | $111,675,644 |
| Testing | $29,333,019 |
| Management and Operations | $1,549,744 |
Budget Codes
| HTXD: Treatment: ARV Drugs | $204,131,784 |
| HLAB: Laboratory Infrastructure | $63,946,505 |
| HTXS: Treatment: Adult Treatment | $61,979,064 |
| HKID: Care: Orphans and Vulnerable Children | $54,807,405 |
| HBHC: Care: Adult Care and Support | $41,529,222 |
| HMIN: Biomedical Prevention: Injection Safety | $33,433,086 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $33,318,274 |
| HVSI: Strategic Information | $30,516,784 |
| HVCT: Testing: HIV Testing and Counseling | $29,333,019 |
| OHSS: Health Systems Strengthening | $23,796,767 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $20,540,221 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $18,331,436 |
| HVTB: Care: TB/HIV | $15,339,017 |
| HMBL: Biomedical Prevention: Blood Safety | $6,429,450 |
| HVMS: Management and Operations | $1,549,744 |